Naoya Kinomura is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address serious neurological conditions. With a total of 2 patents, his work focuses on innovative solutions for mental health disorders.

Latest Patents

Kinomura's latest patents include an N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof. This invention provides compounds that demonstrate high effectiveness against positive symptoms, negative symptoms, and cognitive dysfunction in schizophrenia. It also aims to reduce conventional side-effect risks while offering remarkable effects for central neurological diseases associated with cognitive dysfunction beyond schizophrenia. Another significant patent is a β-secretase inhibitor, which relates to a compound useful for preventing or treating Alzheimer's disease.

Career Highlights

Throughout his career, Kinomura has worked with Dainippon Sumitomo Pharma Co., Ltd., where he has contributed to various innovative projects. His expertise in pharmaceutical development has positioned him as a key figure in the industry.

Collaborations

Kinomura has collaborated with notable coworkers such as Satoshi Nojima and Tsutomu Mimoto, enhancing the impact of his research and inventions.

Conclusion

Naoya Kinomura's contributions to pharmaceutical innovations highlight his commitment to addressing critical health issues. His patents reflect a deep understanding of complex neurological conditions and a dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com